Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded down 8.3% during mid-day trading on Tuesday . The stock traded as low as $1.00 and last traded at $1.00. 2,410 shares changed hands during trading, a decline of 73% from the average session volume of 9,053 shares. The stock had previously closed at $1.09.
Peak Pharmaceuticals Stock Performance
The firm has a 50 day simple moving average of $1.09 and a 200-day simple moving average of $1.71.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Stories
- Five stocks we like better than Peak Pharmaceuticals
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
